×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2 - Raw Material Requirements for Regenerative Medicine
Session Chair(s)
Teruyo Arato, PhD
Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan
Speaker(s)
Approval and PMS Issues of An Allogeneic Stem Cell Product “TEMCELLl® HS inj”
Zen-ichi Mohri
JCR Pharmaceuticals Co., Ltd., Japan
Advisor for Development
Issue and Challenge for Quality Strategy on Global Development Products
Ian Harris, PhD
Janssen Research & Development, LLC, A Pharmaceutical Company of Johnson & Johns, United States
Product Development Team Leader, Cell Therapy
Assessment of Raw and Starting Materials for Cell-Based Therapies - European Regulatory Aspects
Ivana Haunerova
State Institute for Drug Control, Czech Republic
Pharmaceutical Assessor - Specialist
Have an account?